The response of γ vitamin E to varying dosages of α vitamin E plus vitamin C

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 469-478

  Gutierrez, Absalon D ^a   de Serna, Daniela Gonzalez ^a   Robinson, Irina ^a   Schade, David S ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GAMMA TOCOPHEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ASCORBIC ACID; ATHEROSCLEROSIS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; VITAMIN E;

EID: 62349096829     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.003     Document Type: Article

References (72)

1. Neuzil J., Weber C., and Kontush A. The role of Vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 157 (2001) 257-283
2. Jiang Q., Christen S., Shigenaga M., and Ames B.N. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 74 (2001) 714-722
3. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., and Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328 (1993) 1450-1456
4. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., and Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328 (1993) 1444-1449
5. Pruthi S., Allison T.G., and Hensrud D. Vitamin E supplementation in the prevention of coronary heart disease. Mayo Clin Proc 76 (2001) 1131-1136
6. Miller III E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142 (2005) 37-46
7. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., et al. Vitamin E in the primary prevention of cardiovascular disease and cancer. The Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 56-65
8. Lonn E., Bosch J., Sheridan P., Pogue J., Arnold J.M., et al. The HOPE and HOPE-TOO trial investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer. JAMA 293 (2005) 1338-1347
9. Yusuf S., Dagenais G., Bosch J., and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 154-160
10. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54 (1991) 1113S-1118S
11. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr 54 (1991) 1119S-1124S
12. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., and Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97 (1996) 22-28
13. Carr A., Zhu B.Z., and Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and α-tocopherol (vitamin E). Circ Res 87 (2000) 349-354
14. Fang J.C., Kinlay S., Beltrame J., Hikiti H., Wainstein M., Behrendt D., et al. Effects of vitamins C and E on the progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 359 (2002) 1108-1113
15. Salonen J.T., Nyyssonen K., Salonen R., Lakka H.M., Kaikkonen J., Porkkala-Sarataho E., et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248 (2000) 377-386
16. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic program: the Antioxidant Supplementation in Atherosclerosis Prevention study (ASAP). Circulation 107 (2003) 947-953
17. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., et al. Secondary Prevention with Antioxidants of Cardiovascular disease in Endstage renal disease (SPACE): randomized placebo-controlled trial. Lancet 356 (2000) 1213-1218
18. Huang H., and Appel L.J. Supplementation of diets with alpha-tocopherol reduces serum concentrations of γ- and δ-tocopherol in humans. J Nutr 133 (2003) 3137-3140
19. Handelman G.J., Machlin L.J., Fitch K., Weiter J.J., and Dratz E.A. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol. J Nutr 115 (1985) 807-813
20. Thurnham D.I., Davies J.A., Crump B.J., Situnayake R.D., and Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 23 (1986) 514-520
21. Hansen L.G., and Warwick W.J. An improved assay method for serum vitamins A and E using fluorometry. Am J Clin Pathol 70 (1978) 922-923
22. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., and Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98 (1998) 1487-1494
23. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
24. Blankenberg S., Rupprecht H.J., Bickel C., Torzewski M., Hafner G., Tiret L., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Eng J Med 349 (2003) 1605-1613
25. Yeo H.C., Helbock H.J., Chyu D.W., and Ames B.N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal Biochem 220 (1994) 391-396
26. Elphick M.C. Modified colorimetric ultramicro method for estimating NEFA in serum. J Clin Pathol 21 (1968) 567-570
27. Roberts W.L., Moulton L., Law T.C., Farrow G., Cooper-Anderson M., Savory J., et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 47 (2001) 418-425
28. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 50 (2004) 219-221
29. Moody MD, Van Arsdell SW, Murphy KP, Orencole SF, Burns C. Array-based ELISAs for high-throughput analysis of human cytokines. Biotechniques 2001;31:186-90,192-94.
30. Declerck P.J., Alessi M.C., Verstreken M., Kruithof E.D., Juhan-Vague I., and Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 71 (1988) 220-225
31. Geffken D.F., Keating F.G., Cornell E.S., Bovill E.G., and Tracy R.P. The measurement of fibrinogen in population-based research. Studies on instrumentation and methodology. Arch Pathol Lab Med 118 (1994) 1106-1109
32. Bondar R.J., and Mead D.C. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in hexokinase method for determining glucose in serum. Clin Chem 20 (1974) 586-590
33. Hardy R.W., Cohn M., and Konrad R.J. Automated chemiluminescent assay for C-peptide. J Clin Lab Anal 14 (2000) 17-19
34. Andersen L., Dinesen B., Jorgensen P.N., Poulsen F., and Roder M.E. Enzyme immunoassay for intact insulin in serum or plasma. Clin Chem 39 (1993) 578-582
35. Fossati P., and Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28 (1982) 2077-2080
36. Allain C.C., Poon L.S., Chan C.S., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
37. Handelman G.J., Machlin L.J., Fitch K., Weiter J.J., and Dratz E.A. Oral alpha-tocopherol supplements decrease plasma gamma tocopherol levels in humans. J Nutr 348 (1985) 241-251
38. Carroll M.F., and Schade D.S. Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 108 (2003) 24-31
39. Iuliano L., Micheletta F., Maranghi M., Frati G., Diczfalusy U., and Violi F. Bioavailability of vitamin E as function of food intake in healthy subjects. Arterioscler Thromb Vasc Biol 21 (2001) e34-e37
40. Brigelius-Flohe R., and Traber M. Vitamin E: function and metabolism. FASEB J 13 (1999) 1145-1155
41. Neuzil J., Thomas S.R., and Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic Biol Med 22 (1997) 57-71
42. Suarna C., Dean R.T., May J., and Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 15 (1995) 1616-1624
43. Bruno R.S., Leonard S.W., Atkinson J., Montine T.J., Ramakrishnan R., Bray T.M., et al. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med 40 (2006) 689-697
44. Ceriello A., Bortolotti N., Motz E., Crescentini A., Lizzio S., Russo A., et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21 (1998) 1529-1533
45. Nappo F., Esposito K., Cioffi M., Giugliano G., Molinari A.M., Paolisso G., et al. Postprandial endothelial activation in healthy subjects in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll of Cardiol 39 (2002) 1145-1150
46. Liu L., Meydani M., and Mayer J. Combined vitamin C and E supplementation retards early progression of arteriosclerosis in heart transplant patients. Nutr Rev 60 (2002) 368-371
47. Steinberg D., and Witztum J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?. Circulation 1015 (2002) 2107-2111
48. Plotnick G.D., Corretti M.C., and Vogel R.A. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 278 (1997) 1682-1686
49. Vogel R.A., Corretti M.C., and Plotnick G.D. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 79 (1997) 350-354
50. McSavage J., and Trevisan S. The use and abuse of frying oil. Food Serv technol 1 (2001) 85-92
51. Williams M.J., Sutherland W.H., McCormick M.P., de Jong S.A., Walker R.J., and Wilkins G.T. Impaired endothelial function following a meal rich in used cooking fat. J Am Coll Cardiol 33 (1999) 1050-1055
52. Witzum J.L., and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88 (1991) 1785-1792
53. Murakami K., Kondo T., Ohtsuka Y., Fujiwara Y., Shimada M., and Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38 (1989) 753-758
54. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
55. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. JAMA 294 (2005) 56-65
56. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
57. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1736
58. Devaraj S., Chan Jr. A.V., and Jialal I. Alpha-tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients. Diabetes Care 25 (2002) 524-529
59. Lehmann J., Martin H.L., Lashley E.L., Marshall M.W., and Judd J.T. Vitamin E in foods from high and low linoleic acid diets. J Am Diet Assoc 86 (1986) 1208-1216
60. Bieri J.C., and Evarts R.P. Tocopherols and fatty acids in American diets. J Am Diet Assoc 62 (1973) 147-151
61. Saldeen T., Li D., and Mehta J.L. Differential effects of α- and γ-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation, and arterial thrombogenesis. J Am Coll Cardiol 34 (1999) 1208-1215
62. Jiang Q., Elson-Schwab I., Courtemanche C., and Ames B.N. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 97 (2000) 11494-11499
63. Cooney R.V., Franke A.A., Harwood P.J., Hatch-Pigott V., Custer L.J., and Mordan L.J. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc Natl Acad Sci U S A 90 (1993) 1771-1775
64. Ohrvall M., Sundlof G., and Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 239 (1996) 111-117
65. Kontush A., Spranger T., Reich A., Baum K., and Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis 144 (1999) 117-122
66. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., and Bostick R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Eng J Med 334 (1996) 1156-1162
67. Yochum L.A., Folsom A.R., and Kushi L.H. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 72 (2000) 476-483
68. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., et al. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Letters 409 (1997) 105-108
69. Catignani G.L., and Bieri J.G. Rat liver alpha-tocopherol binding protein. Biochim Biophys Acta 497 (1977) 349-357
70. Robinson I., Gonzalez de Serna D., Gutierrez A., and Schade D.S. Vitamin E in man-an explanation of clinical trial failure. Endocr Pract 12 (2006) 576-582
71. Devaraj S., Leonard S., Trabet M.G., and Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 44 (2008) 1203-1208
72. Tessier D., Khalil A., Trottier L., and Fülöp T. Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes. Arch Geront Geriatr (2008) 10.1016/i.archger.2007.10.005